64978--3/13/2006--MERCK_&_CO_INC

related topics
{property, intellectual, protect}
{product, candidate, development}
{product, market, service}
{financial, litigation, operation}
Certain of the Company s major products are going to lose patent protection in the near future and, when that occurs, the Company expects a significant decline in sales of those products. The Company s research and development efforts may not succeed in developing commercially successful products and the Company may not be able to acquire commercially successful products in other ways; in consequence, the Company may not be able to replace sales of successful products that have lost patent protection. The Company s products, including products in development, can not be marketed unless the Company obtains and maintains regulatory approval. The Company is dependent on its patent rights, and if its patent rights are invalidated or circumvented, its business would be adversely affected. The Company faces intense competition from lower-cost generic products. The Company faces intense competition from new products. Cautionary Factors that May Affect Future Results

Full 10-K form ▸

related documents
64978--2/28/2007--MERCK_&_CO_INC
886530--3/16/2007--DATATRAK_INTERNATIONAL_INC
28626--9/13/2007--LIFECORE_BIOMEDICAL_INC
886530--3/17/2008--DATATRAK_INTERNATIONAL_INC
724004--6/29/2009--MESA_LABORATORIES_INC_/CO
724004--6/30/2008--MESA_LABORATORIES_INC_/CO
874734--3/12/2008--OSTEOTECH_INC
886530--3/13/2006--DATATRAK_INTERNATIONAL_INC
724004--6/29/2010--MESA_LABORATORIES_INC_/CO
899866--2/23/2009--ALEXION_PHARMACEUTICALS_INC
886530--3/16/2009--DATATRAK_INTERNATIONAL_INC
1436083--7/20/2009--New_Millennium_Products
880432--9/28/2007--MISONIX_INC
1029023--3/2/2009--SYNTROLEUM_CORP
1101026--4/14/2010--HEALTH_ENHANCEMENT_PRODUCTS_INC
1114200--2/28/2007--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC
1101026--5/18/2009--HEALTH_ENHANCEMENT_PRODUCTS_INC
949858--3/16/2006--SONUS_PHARMACEUTICALS_INC
1129096--10/29/2008--INFITECH_VENTURES_INC
855683--3/17/2009--MILESTONE_SCIENTIFIC_INC/NJ
758004--12/21/2007--NOVELL_INC
906193--12/13/2006--KEY_TECHNOLOGY_INC
1114200--3/1/2010--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC
918580--3/30/2009--Gaming_Partners_International_CORP
28626--9/13/2006--LIFECORE_BIOMEDICAL_INC
1043894--4/15/2009--ENVIRO_VORAXIAL_TECHNOLOGY_INC
1116463--3/10/2009--ORASURE_TECHNOLOGIES_INC
1279695--3/28/2008--UNIVERSAL_BIOSENSORS_INC
202058--8/26/2008--HARRIS_CORP_/DE/
20740--1/28/2008--CLARCOR_INC